The gut microbiome and microbial translocation in multiple sclerosis

被引:52
作者
Mirza, Ali [1 ,2 ]
Mao-Draayer, Yang [3 ]
机构
[1] Univ Michigan, Sch Med, Dept Microbiol & Immunol, 4258 Alfred Taubman Biomed Sci Res Bldg, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Sch Med, Dept Neurol, 4258 Alfred Taubman Biomed Sci Res Bldg, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Sch Med, Dept Neurol, 4015 Alfred Taubman Biomed Sci Res Bldg, Ann Arbor, MI 48109 USA
关键词
Multiple sclerosis; Microbiome; CNS; Gut-brain axis; Microbial translocation; Intestinal permeability; CHAIN FATTY-ACIDS; BUTYRATE-PRODUCING BACTERIA; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; PATTERN-RECOGNITION RECEPTORS; INTESTINAL BARRIER FUNCTION; INFLAMMATORY-BOWEL-DISEASE; TOLL-LIKE RECEPTORS; REGULATORY T-CELLS; FAECALIBACTERIUM-PRAUSNITZII; FECAL MICROBIOTA;
D O I
10.1016/j.clim.2017.03.001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Individuals with multiple sclerosis (MS) have a distinct intestinal microbial community (microbiota) and increased low-grade translocation of bacteria from the intestines into the circulation. The observed change of intestinal bacteria in MS patients regulate immune functions involved in MS pathogenesis. These functions include: systemic and central nervous system (CNS) immunity (including peripheral regulatory T cell function), the blood-brain barrier (BBB) permeability and CNS-resident cell activity. This review discusses the MS intestinal microbiota implication on MS systemic- and CNS-immunopathology. We introduce the possible contributions of MS low-grade microbial translocation (LG-MT) to the development of MS, and end on a discussion on microbiota therapies for MS patients. (C) 2017 Elsevier Inc. All rights reserved.
引用
收藏
页码:213 / 224
页数:12
相关论文
共 50 条
[31]   Interaction of the Gut Microbiome and Immunity in Multiple Sclerosis: Impact of Diet and Immune Therapy [J].
Yadav, Sudhir Kumar ;
Ito, Kouichi ;
Dhib-Jalbut, Suhayl .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (19)
[32]   Multiple Sclerosis: A Story of the Interaction Between Gut Microbiome and Components of the Immune System [J].
Mohsen, Esraa ;
Haffez, Hesham ;
Ahmed, Sandra ;
Hamed, Selwan ;
El-Mahdy, Taghrid S. .
MOLECULAR NEUROBIOLOGY, 2025, 62 (06) :7762-7775
[33]   Probiotic and commensal gut microbial therapies in multiple sclerosis and its animal models: a comprehensive review [J].
Blais, Lorrie L. ;
Montgomery, Theresa L. ;
Amiel, Eyal ;
Deming, Paula B. ;
Krementsov, Dimitry N. .
GUT MICROBES, 2021, 13 (01)
[34]   Microbial monotherapy with Prevotella histicola for patients with multiple sclerosis [J].
Mangalam, Ashutosh K. ;
Murray, Joseph .
EXPERT REVIEW OF NEUROTHERAPEUTICS, 2019, 19 (01) :45-53
[35]   The Role of Gut Microbiome in the Pathogenesis of Multiple Sclerosis and Related Disorders [J].
Dunalska, Anna ;
Saramak, Kamila ;
Szejko, Natalia .
CELLS, 2023, 12 (13)
[36]   Gut microbiome in multiple sclerosis-related cognitive impairment [J].
Ghadiri, Fereshteh ;
Ebadi, Zahra ;
Asadollahzadeh, Elnaz ;
Moghadasi, Abdorreza Naser .
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 67
[37]   The multiple sclerosis gut microbiome and disease activity: A systematic review [J].
Jette, Sophia ;
de Schaetzen, Constance ;
Tsai, Chia-Chen ;
Tremlett, Helen .
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2024, 92
[38]   The role of the gut microbiota in multiple sclerosis [J].
Correale, Jorge ;
Hohlfeld, Reinhard ;
Baranzini, Sergio E. .
NATURE REVIEWS NEUROLOGY, 2022, 18 (09) :544-558
[39]   FECAL MICROBIAL TRANSPLANT (FMT) IN PERSONS WITH MULTIPLE SCLEROSIS INDUCES EXTENDED CHANGES IN GUT MICROBIOME DIVERSITY AND TAXONOMY [J].
Guarnaccia, Joseph ;
Huang, Juan ;
Pearson, James ;
Wang, Pai ;
Yang, Xin ;
Peng, Jian ;
Ayettey, Rockiy ;
Njike, Valentine ;
Treu, Judy ;
Comerford, Beth ;
Wen, Li .
NEUROPSYCHOPHARMACOLOGY, 2024, 49 :408-408
[40]   Game of microbes: the battle within - gut microbiota and multiple sclerosis [J].
Turner, Ti-Ara ;
Lehman, Peter ;
Ghimire, Sudeep ;
Shahi, Shailesh K. ;
Mangalam, Ashutosh .
GUT MICROBES, 2024, 16 (01)